Be aware, take action: fight counterfeits, keep patients safer

1,038 views

Published on

At the Partnership for Safe Medicines 2011 Interchange conference, Xuanhao Chan from the Int'l. Pharmaceutical Federation talked about the challenges in combating counterfeit medicines today.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,038
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
13
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Be aware, take action: fight counterfeits, keep patients safer

  1. 1. Xuanhao CHANInternational Pharmaceutical Federation (FIP) and WHPA
  2. 2. Background: The 2011 WHPA rapid review of 24 national initiatives review of 24 national initiativescombating counterfeit medicines 3 No collaboration between HCP associations and other stakeholders.  No activities concerning counterfeit medicines documented Limited collaboration among HCP and stakeholders. Groups may  15 organise one‐off activities such as public campaigns Existence of a national stakeholder group with defined structures  6 and scope of work combating counterfeit medicines Nigeria, Indonesia, US,  China Taiwan, Costa Rica and UK
  3. 3. Key observations from the WHPA rapid review of 24 national initiatives combating counterfeit of 24 national initiatives combating counterfeitmedicines• The actual roles played by health professionals in The actual roles played by health professionals in  these countries seem to be very much unclear in the  majority of the countries. • Most of the documented initiatives against  medicines counterfeiting are mainly by government  bodies and their agencies. • Healthcare professionals are often not educated and  informed about their roles in national initiatives.  f d b h l l• Health professionals are not always at the forefront  of the battle against medicines counterfeiting.  f th b ttl i t di i t f iti
  4. 4. WHPA campaign s mandateWHPA campaign’s mandate• To strengthen advocacy for appropriate investments To strengthen advocacy for appropriate investments  in the education and capacity of health professionals  to detect, report and prevent infiltration of  counterfeit medical products in the supply chain. • By establishing dialogue with government bodies and  agencies, inter‐professional and inter‐disciplinary  networks can create an opportunity for knowledge  and resources to be shared and for cost‐effective  and resources to be shared and for cost effective solutions to be initiated. 
  5. 5. San José, 22nd October 2010San José, 22 October 2010
  6. 6. Abuja, 22nd November 2010Abuja, 22 November 2010
  7. 7. Taipei, 30th June 2011Taipei, 30 June 2011
  8. 8. Main elements of the WHPA Call to Action adapted in Africa, Central America and Asia d di f i l i d i• 4 key strategies for the basis of a 4 key strategies for the basis of a  comprehensive regional action plan against  counterfeiting of medical products: counterfeiting of medical products: – Increase capacity of healthcare professionals – Foster regional cooperation initiatives Foster regional cooperation initiatives – Strengthen collaborative practice – Impro e collaboration ith health and Improve collaboration with health and  enforcement authorities plus other key  stakeholders
  9. 9. WHPA toolkit and other campaign resources  www.whpa.org/counterfeit_campaign.htm• Campaign folder, FAQs  p g , Q and introduction• 5 fact sheets for health  professionals, advocates  f l d and patients • Counterfeit medical Counterfeit medical  product sample  reporting form• 2 posters and 3  postcards• WHPA Joint Statement

×